Nykode Therapeutics is a leading clinical-stage biopharmaceutical company. With our intelligent modular platform and tailored hyper-targeting, we’re unlocking unlimited possibilities for the future of medicine.
With our unique and innovative modular vaccine technology, we’re specifically targeting antigens to Antigen Presenting Cells, which are essential for inducing rapid, strong and long-lasting immune responses.
Gaustadalléen 21, 0349 Oslo – Norway
Oct. 7, 2020Stock exchange(s)